Hoda Shamsnajafabadi 👁️🧠

End of an amazing #OptoGRC2026 presenting my work and the gala dinner.

Third day at #OptoGRC2026 — great talks and a beautiful day in Lucca. ☀️🇮🇹

Kicking off #OptoGRC2026 with an inspiring keynote session by Sheena and Ofer — exciting ideas, powerful tools, and a brilliant start to the meeting 🔦🧠.

Excited to present my talk on developmental stage–dependent efficiency of optogenetic gene delivery in human retinal organoids. Join us! #OptoGRC2026 ⚡️

Lovely oxford

View from Magdalen Tower this morning. Over 18,000 people welcomed May Morning in Oxford 👏 📸 Instagram | BethStenlake #MayDay

@grace_borchert @LLHalf @MacularSociety Very interesting, good luck Grace 😍

This weekend I'll be taking part in the London Landmarks Half Marathon @LLHalf and raising funds for the @MacularSociety ! I hope you'll consider contributing to support the great work that the Macular Society do to help people with visual impairment justgiving.com/page/grace-bor…

@grace_borchert @ARVOinfo @NAEVRAdvocacy @AlexPadilla4CA @SenAdamSchiff @SpeakerPelosi @sliccardo Lovely proud of you

Had a fantastic time at ARVO Advocacy Day 2026! Highlighting the importance of vision science with the @ARVOinfo @NAEVRAdvocacy team meeting U.S legislators @AlexPadilla4CA @SenAdamSchiff @SpeakerPelosi @sliccardo on Capitol Hill. #SeeWhatMatters

Delighted to publish our perspectives article on vision restoration, from optogenetic to thermogenetic gene therapy. Grateful to collaborators. journals.lww.com/jcor/fulltext/…

Professor Robert McLaren on research @fightforsightUK youtu.be/V28FB87Z0xU?si…

Very grateful to share our last publication “Pre-existing retinal inflammation exacerbates gene therapy-associated uveitis in more rapidly progressive retinal degeneration” . Thanks to collaborators and Congress Molly 👏. cell.com/molecular-ther…

@grace_borchert @UniofOxford @bodleianlibs Very Beautiful

A gentle sprinkle of snow over Oxford @UniofOxford @bodleianlibs

Pleased to attend the 108th Oxford Ophthalmology Conference 2025 (#OOC108)! Gained insights into retinal gene therapy, ophthalmic AI & clinical ophthalmology, and presented my research on optogenetic gene therapy in human organoids.

Pleased to be selected to observe the Developmental Pathway Funding Scheme (DPFS) May Panel Meeting on 15 May 2025. Looking forward to gaining insight into the DPFS review process and how translational research is evaluated for funding and clinical impact.

Pleased to give an invited oral presentation on our latest work, “Evaluation of AAV-Mediated Optogenetic Expression in Human Retinal Organoids,” at OPTOGEN 2025 (6–8 May) in Copenhagen 🇩🇰

Honored to have presentation in #ARVO 2025 (Salt Lake City, Utah) about optogenetic gene therapy in human retinal organoids.

Huntington's disease was successfully treated for the first time with gene therapy. 75% reduction in symptoms & 113% protection of cognition. This is what a real medical breakthrough looks like.

CRISPR Workshop 2025 @NDCNOxford! Great presentations Sophia, Ahmed and Ben!!

The University of Oxford has retained the number one spot in the THE World University Rankings for a ninth year in a row, but the reputation of the wider UK sector is rapidly eroding Read more: bit.ly/4gZ2ABU #THEunirankings

Exited to share my last publication, Engineered red Opto-mGluR6 Opsins, a red-shifted optogenetic excitation tool, an in vitro study, very interesting optogenetic research. Great thanks to my colleagues in my hometown, always beautiful IRAN🇮🇷. journals.plos.org/plosone/articl…